Immatics N.V. (IMTX)
NASDAQ: IMTX · Real-Time Price · USD
5.70
-0.12 (-2.06%)
At close: Sep 15, 2025, 4:00 PM EDT
5.70
0.00 (0.00%)
After-hours: Sep 15, 2025, 4:12 PM EDT
Immatics Market Cap
Immatics has a market cap or net worth of $692.89 million as of September 15, 2025. Its market cap has decreased by -38.52% in one year.
Market Cap
692.89M
Enterprise Value
157.49M
1-Year Change
-38.52%
Ranking
Category
Stock Price
$5.70
Market Cap Chart
Since December 12, 2018, Immatics's market cap has increased from $172.50M to $692.89M, an increase of 301.67%. That is a compound annual growth rate of 22.85%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 12, 2025 | 707.48M | -16.63% |
| Dec 31, 2024 | 848.62M | -4.80% |
| Dec 29, 2023 | 891.43M | 34.26% |
| Dec 30, 2022 | 663.94M | -21.47% |
| Dec 31, 2021 | 845.50M | 24.56% |
| Dec 31, 2020 | 678.78M | 263.23% |
| Dec 27, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 12, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 678.14B |
| Johnson & Johnson | 428.83B |
| AbbVie | 385.71B |
| UnitedHealth Group | 319.26B |
| AstraZeneca | 247.84B |
| Novo Nordisk | 242.99B |
| Novartis AG | 240.09B |
| Abbott Laboratories | 232.75B |